Literature DB >> 8428209

Effects of hyperkalaemia on the depression of maximum rate of depolarization by class I antiarrhythmic agents in guinea-pig myocardium.

K R Wyse1, V Ye, T J Campbell.   

Abstract

1 Standard microelectrode methods were used to record intracellular action potentials from strips of guinea-pig right ventricular myocardium superfused with either standard physiological saline ([K+] = 5.6 mM) or the same solution modified to contain [K+] = 11.2 mM. 2 The effects on action potential parameters of three therapeutic concentrations of mexiletine, quinidine and disopyramide were studied under both conditions at four different drive rates (interstimulus intervals = 2400, 1200, 600 and 300 ms). 3 Hyperkalaemia in the absence of drugs produced reductions in resting potential (-86.7 +/- 2.5 mV to -71.8 +/- 3.7 mV; n = 30; P < 0.001), maximum rate of depolarization (300 +/- 46.5 V s-1 to 205.6 +/- 37.6 V s-1; P < 0.0001), and action potential duration (205 +/- 26 ms to 188 +/- 32 ms; P < 0.05). 4 All three drugs produced increased depression of maximum rate of depolarization in hyperkalaemia compared to control conditions, but at all three concentrations this enhancement of effect was greater for mexiletine than for quinidine, with disopyramide exhibiting intermediate behaviour. 5 Mexiletine behaved very similarly to therapeutic concentrations of lignocaine as described in previous reports from this laboratory. 6 Quinidine behaved very similarly to Class Ic agents. 7 It is concluded that mexiletine demonstrated significantly greater selectivity for depolarized myocardium than quinidine and that this may have implications in terms of proarrhythmic potential. 8 Disopyramide exhibited intermediate selectivity for depolarized myocardium between mexiletine and quinidine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8428209      PMCID: PMC1907716          DOI: 10.1111/j.1476-5381.1993.tb13471.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  Antiarrhythmic agents: modulated receptor applications.

Authors:  L M Hondeghem
Journal:  Circulation       Date:  1987-03       Impact factor: 29.690

2.  Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias.

Authors:  J Morganroth; J C Somberg; P E Pool; P H Hsu; I K Lee; J Durkee; D M Salerno
Journal:  J Am Coll Cardiol       Date:  1986-01       Impact factor: 24.094

Review 3.  Subgroups of class 1 antiarrhythmic drugs.

Authors:  E M Vaughan Williams
Journal:  Eur Heart J       Date:  1984-02       Impact factor: 29.983

4.  Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification.

Authors:  T J Campbell
Journal:  Cardiovasc Res       Date:  1983-06       Impact factor: 10.787

5.  Long-term oral antiarrhythmic therapy with mexiletine.

Authors:  N P Campbell; J F Pantridge; A A Adgey
Journal:  Br Heart J       Date:  1978-07

6.  Risk factors for the development of proarrhythmic events.

Authors:  J Morganroth
Journal:  Am J Cardiol       Date:  1987-04-30       Impact factor: 2.778

7.  Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogram.

Authors:  J Morganroth; L N Horowitz
Journal:  Am J Cardiol       Date:  1984-02-27       Impact factor: 2.778

8.  Disopyramide: serum level and arrhythmia conversion.

Authors:  A P Niarchos
Journal:  Am Heart J       Date:  1976-07       Impact factor: 4.749

9.  Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide.

Authors:  J Morganroth; J L Anderson; G D Gentzkow
Journal:  J Am Coll Cardiol       Date:  1986-09       Impact factor: 24.094

10.  A randomized, double-blind, parallel group comparison of disopyramide phosphate and quinidine in patients with cardiac arrhythmias.

Authors:  M Arif; J C Laidlaw; C Oshrain; P W Willis; C H Nissen; D J McDermott; W S Smith; A Karim; R R Wilson
Journal:  Angiology       Date:  1983-06       Impact factor: 3.619

View more
  2 in total

1.  Antiarrhythmic drug research.

Authors:  M J A Walker
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

2.  Electrocardiographic interactions between pinacidil, a potassium channel opener and class I antiarrhythmic agents in guinea-pig isolated perfused heart.

Authors:  Q Yang; R Padrini; S Bova; D Piovan; G Magnolfi
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.